CERo Therapeutics Holdings's total assets for Q2 2025 were $6.20M, a decrease of -22.39% from the previous quarter. CERO total liabilities were $7.84M for the fiscal quarter, a -5.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.